These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 12520557

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
    Shao Y, Mukhi V, Goldberg JD.
    Stat Med; 2008 Feb 20; 27(4):504-19. PubMed ID: 17854052
    [Abstract] [Full Text] [Related]

  • 25. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C.
    Pharm Stat; 2007 Feb 20; 6(3):193-203. PubMed ID: 17879327
    [Abstract] [Full Text] [Related]

  • 26. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
    Marubini E, Rebora P, Reina G.
    Ital Heart J Suppl; 2004 Sep 20; 5(9):712-9. PubMed ID: 15568609
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
    Friede T, Mitchell C, Müller-Velten G.
    Biom J; 2007 Dec 20; 49(6):903-16. PubMed ID: 17726715
    [Abstract] [Full Text] [Related]

  • 29. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL, Johnson MF.
    Stat Med; 2003 Jan 30; 22(2):187-200. PubMed ID: 12520556
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Issues on the selection of non-inferiority margin in clinical trials.
    Hou Y, Wu XY, Li K.
    Chin Med J (Engl); 2009 Feb 20; 122(4):466-70. PubMed ID: 19302756
    [Abstract] [Full Text] [Related]

  • 36. Non-inferiority trials in surgical oncology.
    Fueglistaler P, Adamina M, Guller U.
    Ann Surg Oncol; 2007 May 20; 14(5):1532-9. PubMed ID: 17294075
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN, Huang X.
    Clin Trials; 2007 May 20; 4(4):309-17. PubMed ID: 17848492
    [Abstract] [Full Text] [Related]

  • 40. Trials and tribulations of non-inferiority: the ximelagatran experience.
    Kaul S, Diamond GA, Weintraub WS.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):1986-95. PubMed ID: 16325029
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.